Gowling WLG won this year’s LB Award for Life Sciences Team of the Year for its role in advising AstraZeneca on a collaboration and license agreement with biopharmaceutical company Quell Therapeutics worth more than £2bn. LB spoke with two of the partners who worked on the deal to discuss why it’s important and what it means for the team.
Your limit of 1 article in 30 days is up. Please login for full access or subscribe.
Corporate users - click here for simple access (no password needed).
For more information, please contact jasmine.glass@legalbusiness.co.uk
